Sg3 Management, LLC Intellia Therapeutics, Inc. Put Options Transaction History

Sg3 Management, LLC

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 15, 2022	SELL	$100.76 - $138.36 $2.52 Million - $3.46 Million	-25,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$132.37 - $176.78 $7.15 Million - $9.55 Million	-54,000 Reduced 68.35%	25,000 $3.35 Million
Q2 2021 Aug 16, 2021	BUY	$60.88 - $161.91 $4.81 Million - $12.8 Million	79,000 New	79,000 $12.8 Million

315

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.16B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.